Beckman Coulter Receives Grant to Detect Serious COVID-19 Complication in Kids

As of September 24th, BARDA (the Biomedical Advanced Research and Development Authority, a division of the Dept. of Health and Human Services) has spent over $13.3 billion on COVID-19 funding since February. Beckman Coulter, a global clinical diagnostics leader, added their name to that funding list this week.